LUMINARY THERAPEUTICS, INC.

Profile

Company Names

LUMINARY THERAPEUTICS, INC.

Addresses

1200 WASHINGTON AVENUE SOUTH, SUITE 260, MINNEAPOLIS, MN 55415

1621 E. HENNEPIN AVENUE, SUITE 290, MINNEAPOLIS, MN 55414

Phone Numbers

612-309-7653

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$14,502,700.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-10-14 
$1,406,112.00 
$12,388,157.00 
$10,982,045.00 
Equity 
5
2024-11-20 
$5,184,500.00 
$5,920,000.00 
$735,500.00 
Equity 
4
2022-09-28 
$5,222,095.00 
$5,500,000.00 
$277,905.00 
 
3
2021-10-26 
$374,993.00 
$1,500,000.00 
$1,125,007.00 
Equity 
2
2021-01-12 
$825,000.00 
$1,000,000.00 
$175,000.00 
Equity 
1
2019-10-29 
$1,490,000.00 
$1,490,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
CHANCE 
DIRECTOR
GEORGE 
 
COX 
DIRECTOR
JAMES 
 
HAYMAKER 
DIRECTOR, PROMOTER
JIM 
 
HAYMAKER 
DIRECTOR
JOHN 
 
HURLEY 
EXECUTIVE OFFICER
PETER 
 
KOSA 
DIRECTOR
DAVID 
 
LARGAESPADA 
DIRECTOR, PROMOTER, EXECUTIVE OFFICER
JEFF 
 
LITER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TRACEY 
 
LODIE 
DIRECTOR
BRANDEN 
 
MORIARITY 
DIRECTOR
ALEXANDER 
 
NAYDICH 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-09-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-11-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#